Company Overview of Optimer Pharmaceuticals Canada, Inc.
Executive Profile
Pedro LichtingerPresident of Optimer Pharmaceuticals and Chief Executive Officer of Optimer Pharmaceuticals, Optimer Pharmaceuticals Canada, Inc. |
| Age | Total Calculated Compensation | This person is connected to 3 Board Members in 3 different organizations across 4 different industries. See Board Relationships |
| 57 | -- |
Background
Mr. Pedro Lichtinger served as the Chief Executive Officer and President of Optimer Pharmaceuticals, Inc. from May 2010 to February 2013. Mr. Lichtinger served as an Executive of Pfizer, Inc. from 1995 to 2009 and as the President of Pfizer's Global Primary Care Business Unit, where he oversaw operations in North America, Europe, Korea, and Australia with revenues of $23 billion, 15,000 employees, and more than 60 development projects. He served as the President of European ...
Corporate Headquarters----, -- -- Canada Phone: -- Fax: -- Board Members MembershipsMember of Board of Governors 2009-Present Director, Chairman of Compensation Committee and Member of Science & Technology Committee 2010-2013 Former Chief Executive Officer, President, Director and Member of New Hire Stock Option Committee
EducationMBA 1978 University of Pennsylvania - The Wharton School BE Universidad Autonoma de Mexico
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact Optimer Pharmaceuticals Canada, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








